Small Entity Compliance Guide: Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation; Availability, 18849-18850 [2010-8359]
Download as PDF
Federal Register / Vol. 75, No. 70 / Tuesday, April 13, 2010 / Notices
Office, 4770 Buford Highway, NE., Mailstop
K–92, Atlanta, GA 30341, Telephone: (770)
488–3023, E-mail: DYB7@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 5, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–8442 Filed 4–12–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0001]
Food and Drug Administration/National
Heart Lung and Blood Institute/
National Science Foundation
Workshop on Computer Methods for
Cardiovascular Devices: The
Integration of Nonclinical and Clinical
Models; Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
sroberts on DSKD5P82C1PROD with NOTICES
ACTION:
Notice of public workshop.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public workshop entitled ‘‘FDA/NHLBI/
NSF Workshop on Computer Methods
for Cardiovascular Devices: The
Integration of Nonclinical and Clinical
Models.’’ The workshop will include a
smaller, optional session entitled
‘‘Microstructure Modeling Session.’’
FDA is cosponsoring the workshop with
the National Heart Lung and Blood
Institute of the National Institutes of
Health and the National Science
Foundation. The purpose of the
workshop is to facilitate discussion
between FDA and other interested
parties on the use of computational
modeling in the design, development,
and evaluation of cardiovascular
medical devices.
Dates and Times: The optional
session will be held on June 9, 2010,
from 1 p.m. to 5:30 p.m. and the public
workshop will be held on June 10 and
11, 2010, from 8 a.m. to 5 p.m.
Location: The public workshop and
optional session will be held at the
Hilton Washington DC/Rockville
Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Donna R. Lochner,
Center for Devices and Radiological
Health, Food and Drug Administration,
VerDate Nov<24>2008
17:33 Apr 12, 2010
Jkt 220001
10903 New Hampshire Ave., Bldg. 66,
rm. 1110, Silver Spring, MD 20993,
301–796–6309,
donna.lochner@fda.hhs.gov.
Registration: To register for the public
workshop and optional session, please
visit the following Web site: https://
scpd.stanford.edu/
publicViewHome.do?method=load.
There is a registration fee to attend the
public workshop to cover the expenses
and attendees must register in advance.
The fee for the meeting is $350.
Students will be offered a discounted
fee of $175. The exhibitors’ fee is $600
and includes registration of one person.
Fees will be waived for invited speakers
and the organizing committee. The
registration process will be handled by
the Stanford Center for Professional
Development. Although the facility is
spacious, registration will be on a firstcome, first-served basis.
If you need special accommodations
because of a disability, please contact
Donna R. Lochner at least 7 days before
the public workshop.
SUPPLEMENTARY INFORMATION:
I. Why Are We Holding This Public
Workshop?
The purpose of the public workshop
is to facilitate discussion between FDA
and other interested parties on the use
of computational modeling in
cardiovascular device design,
development, and evaluation.
II. What Are the Topics We Intend to
Address at the Public Workshop?
We hope to discuss a large number of
issues at the public workshop, with our
overall theme being the integration of
computer and nonclinical models.
Topics include, but are not limited to
the following:
• Multiscale, multiphysics, and
multiphase modeling;
• Modeling of cardiovascular diseases
and therapies;
• Patient-specific modeling,
including virtual surgical planning and
predictive biomedicine;
• Open source projects, including
public policy initiatives, database
development and data presentation, and
standards and protocols; and
• Regulatory issues with
implementation of computer modeling.
III. Where Can I Find Out More About
This Public Workshop?
Background information on the public
workshop, registration information, the
agenda, information about lodging, and
other relevant information will be
posted, as it becomes available, on the
Internet at https://www.fda.gov/
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
18849
MedicalDevices/NewsEvents/
WorkshopsConferences/default.htm
Dated: April 7, 2010.
Jeffrey Shuren,
Director, Center for Devices and Radiological
Health.
[FR Doc. 2010–8311 Filed 4–12–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0183]
Small Entity Compliance Guide:
Prevention of Salmonella Enteritidis in
Shell Eggs During Production,
Storage, and Transportation;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a guidance entitled
‘‘Prevention of Salmonella Enteritidis in
Shell Eggs During Production, Storage,
and Transportation—Small Entity
Compliance Guide.’’ The small entity
compliance guide (SECG) is being
issued for a final rule published in the
Federal Register of July 9, 2009, and is
intended to set forth in plain language
the requirements of the regulation and
to help small businesses understand the
regulation. Elsewhere in this issue of the
Federal Register, FDA is amending its
July 9, 2009, regulation to correct the
date by which producers must register
their farm with FDA, reflect a change in
the address and telephone number for
requesting copies of Form No. 3733, and
reflect a change in the address to which
producers must send their CD–ROM.
DATES: Submit electronic or written
comments on the SECG at any time.
ADDRESSES: Submit electronic
comments on the SECG to https://
www.regulations.gov. Submit written
comments on the SECG to the Division
of Dockets Management (HFA–305),
Food and Drug Administration, 5630
Fishers Lane, rm. 1061, Rockville, MD
20852. Submit written requests for
single copies of the SECG to the
Division of Plant and Dairy Food Safety/
Office of Food Safety, Center for Food
Safety and Applied Nutrition (HFS–
315), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740, or fax your request to 301–
436–1070. Send two self-addressed
adhesive labels to assist that office in
processing your request. See the
E:\FR\FM\13APN1.SGM
13APN1
18850
Federal Register / Vol. 75, No. 70 / Tuesday, April 13, 2010 / Notices
section for
electronic access to the SECG.
FOR FURTHER INFORMATION CONTACT:
Nancy S. Bufano, Center for Food Safety
and Applied Nutrition (HFS–315), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740,
301–436–1493.
SUPPLEMENTARY INFORMATION:
SUPPLEMENTARY INFORMATION
I. Background
In the Federal Register of July 9, 2009
(74 FR 33030), FDA issued a final rule
requiring shell egg producers to
implement measures to prevent
Salmonella Enteritidis (SE) from
contaminating eggs on the farm and
from further growth during storage and
transportation, and requiring these
producers to maintain records
concerning their compliance with the
rule and to register with FDA. The final
rule became effective September 8,
2009.
FDA examined the economic
implications of the final rule as required
by the Regulatory Flexibility Act (5
U.S.C. 601–612) and determined that
the final rule will have a significant
economic impact on a substantial
number of small entities. In compliance
with section 212 of the Small Business
Regulatory Enforcement Fairness Act
(Public Law 104–121), FDA is making
available this SECG stating in plain
language the requirements of the
regulation.
FDA is issuing this SECG as level 2
guidance consistent with FDA’s good
guidance practices regulation (21 CFR
10.115(c)(2)). The SECG represents
FDA’s current thinking on the
prevention of SE in shell eggs. It does
not create or confer any rights for or on
any person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statutes and regulations.
modify, or disapprove the information
collection provisions in this final rule.
An agency may not conduct or sponsor,
and a person is not required to respond
to, a collection of information unless it
displays a currently valid OMB control
number.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) electronic or written
comments regarding this SECG. Submit
a single copy of electronic comments or
two paper copies of any mailed
comments, except that individuals may
submit one paper copy. Comments are
to be identified with the docket number
found in brackets in the heading of this
document. The SECG and received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
IV. Electronic Access
Persons with access to the Internet
may obtain the document at https://
www.fda.gov/FoodGuidances or https://
www.regulations.gov.
Dated: April 7, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–8359 Filed 4–12–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2009–0026]
National Protection and Programs
Directorate; Chemical Facility AntiTerrorism Standards Personnel Surety
Program
sroberts on DSKD5P82C1PROD with NOTICES
II. Paperwork Reduction Act of 1995
AGENCY: National Protection and
Programs Directorate, DHS.
ACTION: 30-day notice and request for
comments: New information collection
request 1670–NEW.
This SECG refers to collections of
information described in FDA’s final
rule that published in the Federal
Register of July 9, 2009 (74 FR 33030 at
33089), and that became effective on
September 8, 2009. As stated in the final
rule, these collections of information are
subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(the PRA) (44 U.S.C. 3501–3520). In
compliance with the PRA (44 U.S.C.
3507(d)), the agency has submitted the
information collection provisions of the
final rule to OMB for review. FDA will
publish a notice in the Federal Register
announcing OMB’s decision to approve,
The Department of Homeland
Security (DHS), National Protection and
Programs Directorate (NPPD), Office of
Infrastructure Protection (IP),
Infrastructure Security Compliance
Division (ISCD) will be submitting the
following information collection request
(ICR) to the Office of Management and
Budget (OMB) for review and clearance
in accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is a new
information collection. A 60-day public
notice for comments was previously
published in the Federal Register on
June 10, 2009, at 74 FR 27555.
Comments were received and responses
VerDate Nov<24>2008
17:33 Apr 12, 2010
Jkt 220001
SUMMARY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
are in this notice. The purpose of this
notice is to solicit additional comments
during a 30-day public comment period
prior to the submission of this collection
to OMB. The submission describes the
nature of the information collection, the
categories of respondents, the estimated
burden, and cost.
DATES: Comments are encouraged and
will be accepted until May 13, 2010.
This process is conducted in accordance
with 5 CFR 1320.8.
ADDRESSES: Interested persons are
invited to submit comments on the
proposed information collection
through the Federal Rulemaking Portal
at https://www.regulations.gov. Follow
the instructions for submitting
comments. Comments must be
identified by docket number DHS–
2009–0026.
Comments that include trade secrets,
confidential commercial or financial
information, Chemical-terrorism
Vulnerability Information (CVI),
Sensitive Security Information (SSI), or
Protected Critical Infrastructure
Information (PCII) should not be
submitted to the public regulatory
docket. Please submit such comments
separately from other comments in
response to this notice. Comments
containing trade secrets, confidential
commercial or financial information,
CVI, SSI, or PCII should be
appropriately marked and submitted by
mail to the DHS/NPPD/IP/ISCD CFATS
Program Manager at the Department of
Homeland Security, 245 Murray Lane,
SW., Mail Stop 0610, Arlington, VA
20528–0610. Comments must be
identified by docket number DHS–
2009–0026.
FOR FURTHER INFORMATION CONTACT: A
copy of this ICR, with applicable
supporting documentation, may be
obtained through the Federal
Rulemaking Portal at https://
www.regulations.gov.
SUPPLEMENTARY INFORMATION:
Program Description
The Chemical Facility Anti-Terrorism
Standards (CFATS), 6 CFR part 27,
require high-risk chemical facilities to
submit information about facility
personnel and, as appropriate,
unescorted visitors with access to
restricted areas or critical assets at those
facilities. This information will be
vetted by the Federal Government
against the Terrorist Screening Database
(TSDB), the consolidated and integrated
terrorist watchlist maintained by the
Federal Government, to identify known
or suspected terrorists (i.e., individuals
with terrorist ties).
E:\FR\FM\13APN1.SGM
13APN1
Agencies
[Federal Register Volume 75, Number 70 (Tuesday, April 13, 2010)]
[Notices]
[Pages 18849-18850]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8359]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-D-0183]
Small Entity Compliance Guide: Prevention of Salmonella
Enteritidis in Shell Eggs During Production, Storage, and
Transportation; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a guidance entitled ``Prevention of Salmonella
Enteritidis in Shell Eggs During Production, Storage, and
Transportation--Small Entity Compliance Guide.'' The small entity
compliance guide (SECG) is being issued for a final rule published in
the Federal Register of July 9, 2009, and is intended to set forth in
plain language the requirements of the regulation and to help small
businesses understand the regulation. Elsewhere in this issue of the
Federal Register, FDA is amending its July 9, 2009, regulation to
correct the date by which producers must register their farm with FDA,
reflect a change in the address and telephone number for requesting
copies of Form No. 3733, and reflect a change in the address to which
producers must send their CD-ROM.
DATES: Submit electronic or written comments on the SECG at any time.
ADDRESSES: Submit electronic comments on the SECG to https://www.regulations.gov. Submit written comments on the SECG to the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit written
requests for single copies of the SECG to the Division of Plant and
Dairy Food Safety/Office of Food Safety, Center for Food Safety and
Applied Nutrition (HFS-315), Food and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740, or fax your request to 301-436-
1070. Send two self-addressed adhesive labels to assist that office in
processing your request. See the
[[Page 18850]]
SUPPLEMENTARY INFORMATION section for electronic access to the SECG.
FOR FURTHER INFORMATION CONTACT: Nancy S. Bufano, Center for Food
Safety and Applied Nutrition (HFS-315), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740, 301-436-1493.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of July 9, 2009 (74 FR 33030), FDA issued
a final rule requiring shell egg producers to implement measures to
prevent Salmonella Enteritidis (SE) from contaminating eggs on the farm
and from further growth during storage and transportation, and
requiring these producers to maintain records concerning their
compliance with the rule and to register with FDA. The final rule
became effective September 8, 2009.
FDA examined the economic implications of the final rule as
required by the Regulatory Flexibility Act (5 U.S.C. 601-612) and
determined that the final rule will have a significant economic impact
on a substantial number of small entities. In compliance with section
212 of the Small Business Regulatory Enforcement Fairness Act (Public
Law 104-121), FDA is making available this SECG stating in plain
language the requirements of the regulation.
FDA is issuing this SECG as level 2 guidance consistent with FDA's
good guidance practices regulation (21 CFR 10.115(c)(2)). The SECG
represents FDA's current thinking on the prevention of SE in shell
eggs. It does not create or confer any rights for or on any person and
does not operate to bind FDA or the public. An alternative approach may
be used if such approach satisfies the requirements of the applicable
statutes and regulations.
II. Paperwork Reduction Act of 1995
This SECG refers to collections of information described in FDA's
final rule that published in the Federal Register of July 9, 2009 (74
FR 33030 at 33089), and that became effective on September 8, 2009. As
stated in the final rule, these collections of information are subject
to review by the Office of Management and Budget (OMB) under the
Paperwork Reduction Act of 1995 (the PRA) (44 U.S.C. 3501-3520). In
compliance with the PRA (44 U.S.C. 3507(d)), the agency has submitted
the information collection provisions of the final rule to OMB for
review. FDA will publish a notice in the Federal Register announcing
OMB's decision to approve, modify, or disapprove the information
collection provisions in this final rule. An agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
III. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) electronic or written comments regarding this SECG.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. The SECG and received comments may be
seen in the Division of Dockets Management between 9 a.m. and 4 p.m.,
Monday through Friday.
IV. Electronic Access
Persons with access to the Internet may obtain the document at
https://www.fda.gov/FoodGuidances or https://www.regulations.gov.
Dated: April 7, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-8359 Filed 4-12-10; 8:45 am]
BILLING CODE 4160-01-S